middle.news
Universal Biosensors Boosts Q1 Receipts 28% Ahead of New Product Launch
5:44am on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
Universal Biosensors Boosts Q1 Receipts 28% Ahead of New Product Launch
5:44am on Monday 2nd of June, 2025 AEST
Key Points
28% increase in receipts from customers to $1.6 million in Q1 2025
Operating cash outflows improved by $2 million compared to Q1 2024
Cash and cash equivalents stood at $4.9 million at quarter-end
FDA approval for Xprecia achieved in 2024, driving sales momentum
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Universal Biosensors (ASX:UBI)
OPEN ARTICLE